News

UBS and Reef complete Stevenage land deal for 2.5m sq ft lab scheme

By 2022-11-14T11:17:00

Stevenage

UBS Asset Management and Reef Group have completed the purchase of development land that sits alongside GSK’s 1m sq ft research and development scheme in Stevenage.

UBS Asset Management and Reef Group, which bought the site from the pharmaceutical giant, are set to invest up to £900m to develop the 33 acres of land adjacent to GSK’s R&D hub to create a combined campus of 2.5m sq ft of laboratory and office facilities.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.

Registered users and subscribers SIGN IN here to continue